Pathogen-specific T Regulatory 1 Cells Induced in the Respiratory Tract by a Bacterial Molecule that Stimulates Interleukin 10 Production by Dendritic Cells: A Novel Strategy for Evasion of Protective T Helper Type 1 Responses by Bordetella pertussis by McGuirk, Peter et al.
 
J. Exp. Med. 
 

 
 The Rockefeller University Press • 0022-1007/2002/01/221/11 $5.00
Volume 195, Number 2, January 21, 2002 221–231
http://www.jem.org/cgi/content/full/195/2/221
 
221
 
Pathogen-speciﬁc T Regulatory 1 Cells Induced in the 
Respiratory Tract by a Bacterial Molecule that Stimulates 
Interleukin 10 Production by Dendritic Cells: A Novel 
Strategy for Evasion of Protective T Helper Type 1 Responses 
 
by 
 
Bordetella pertussis
 
Peter McGuirk, Chantelle McCann, and Kingston H.G. Mills
 
Immune Regulation Research Group, Department of Biochemistry, Trinity College, Dublin 2, Ireland
 
Abstract
 
Antigen-specific T helper type 1 (Th1) cells mediate protective immunity against a range of in-
 
fectious diseases, including that caused by 
 
Bordetella pertussis
 
. Distinct T cell subtypes that se-
crete interleukin (IL)-10 or tumor growth factor (TGF)-
 
 
 
 are considered to play a role in the
maintenance of self-tolerance. However, the antigens recognized by these regulatory T cells in
vivo have not been defined. Here we provide the first demonstration of pathogen-specific T
regulatory type 1 (Tr1) cells at the clonal level and demonstrate that these cells are induced at a
mucosal surface during an infection where local Th1 responses are suppressed. Tr1 clones spe-
cific for filamentous hemagglutinin (FHA) and pertactin were generated from the lungs of mice
during acute infection with 
 
B. pertussis
 
. The Tr1 clones expressed T1/ST2 and CC chemokine
receptor 5, secreted high levels of IL-10, but not IL-4 or interferon (IFN)-
 
 
 
, and suppressed
Th1 responses against 
 
B. pertussis
 
 or an unrelated pathogen. Furthermore, FHA inhibited IL-12
and stimulated IL-10 production by dendritic cells (DCs), and these DCs directed naive T cells
into the regulatory subtype. The induction of Tr1 cells after interaction of a pathogen-derived
molecule with cells of the innate immune system represents a novel strategy exploited by an in-
fectious pathogen to subvert protective immune responses in vivo
 
.
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Introduction
 
CD4
 
 
 
 T cell subtypes have been distinguished on the basis
of their cytokine profile, function, and more tentatively by
surface antigen expression. Th1 and Th2 clones have been
generated against a range of infectious pathogens and al-
though distinct subtypes of T cells with regulatory func-
 
tion, termed Tr1
 
*
 
 (1–4) or Th3 (4–6) cells, that secrete
high levels of IL-10 or TGF-
 
 
 
 respectively, have been de-
scribed; these cells have been more difficult to culture in
vitro. OVA-specific Tr1 clones have been generated in
vitro by culture of naive T cells in the presence of IL-10
 
and have been shown to be capable of inhibiting Th1-medi-
ated colitis in a murine model. However, little is known
about the induction of T regulatory cells in vivo, the anti-
gens they recognized or the factors that control their differ-
entiation from naive T cells.
Dendritic cells (DCs) are considered to be the key anti-
gen-presenting cell for activation of naive T cells (7). Bind-
ing of conserved pathogen-derived molecules to pathogen
recognition receptors (PRRs), including Toll-like recep-
tors, on DCs activates transcription of genes coding for
MHC and costimulatory molecules and in the production
of inflammatory cytokines (8, 9). This process of matura-
tion is accompanied by migration of DCs to the local
lymph node where they function as an APC to activate na-
ive T cells (7). Certain pathogen-derived molecules, nota-
 
bly LPS from Gram-negative bacteria and CpG motifs from
 
bacterial DNA, can stimulate immature bone marrow–
derived DCs into a phenotype, termed DC1, that selectively
enhance the differentiation of naive T cells into Th1 cells
(9, 10). Conversely cholera bacterial toxins and molecules
from helminth pathogens appear to be capable of driving
immature DCs into a phenotype, termed DC2, that selec-
tively enhance Th2 induction (7, 10, 11). While there have
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been no definitive reports on a DC phenotype that drives
Tr1 or Th3 cells, it has been shown that repeated stimula-
tion of naive human T cells with allogeneic immature DCs
preferentially activated IL-10–producing nonproliferating
CD4
 
 
 
 T cells (12).
 
Bordetella pertussis
 
 causes a protracted and severe disease,
which is often complicated by secondary infection and
pneumonia, and can have a lethal outcome in young chil-
dren (13). Recovery from infection is associated with the
development of 
 
B. pertussis
 
–specific Th1 cells (14, 15) and
these cells play a critical role in clearance of the bacteria
from the respiratory tract (14, 16, 17). However, antigen-
specific Th1 responses in the lung and local lymph nodes
are severely suppressed during the acute phase of infection
(18). 
 
B. pertussis
 
 has evolved a number of strategies to cir-
cumvent protective immune responses (19). We have
found that one virulence factor, filamentous hemagglutinin
(FHA), is capable of inhibiting LPS-driven IL-12 produc-
tion by macrophages, IL-12 and IFN-
 
 
 
 production in a
murine model of septic shock (20), and Th1 responses to
an unrelated pathogen, influenza virus, when administered
simultaneously to the respiratory tract (21). FHA is consid-
ered to function primarily as an adhesin, mediating binding
of 
 
B. pertussis
 
 to the 
 
 
 
2-integrin (CR3, CD11b/CD18,
 
 
 
M
 
 
 
2) via binding to leukocyte response integrin (
 
 
 
V
 
 
 
3,
CD61) and the integrin-associated protein (CD47) com-
plex (22). In the present study we addressed the hypothesis
that FHA may contribute to suppressed Th1 responses dur-
ing acute infection with 
 
B. pertussis
 
 by the induction of T
cells with regulatory activity, as a result of its interaction
with cells of the innate immune system. We demonstrate
that FHA interacts directly with DCs to induce IL-10 and
inhibit LPS-induced IL-12 and inflammatory chemokine
production. The DCs generated after interaction with
FHA selectively stimulates the induction of Tr1 cells from
naive T cells. Tr1 clones specific for FHA and pertactin
(PRN) from 
 
B. pertussis
 
 were generated from the lungs of
acutely infected mice. These Tr1 cells secreted high levels
of IL-10 and inhibited protective Th1 responses against 
 
B.
pertussis 
 
in vitro and in vivo
 
.
 
 Our study demonstrates a
novel function for Tr1 cells, exploited by a respiratory
pathogen to evade protective immunity, and provides evi-
dence that these regulatory cells are induced by DCs in
which IL-10 production is activated and IL-12 suppressed
after interaction with a pathogen-derived molecule.
 
Materials and Methods
 
Animals.
 
Female BALB/c mice purchased from Harlan UK.
BALB/c mice expressing a transgene for the DO11.10 TCR spe-
cific for amino acids 323–339 of OVA and I-A
 
d
 
 (DO.11.10 TCR
transgenic [Tg] mice; reference 23) were obtained from the Bio-
medical Services, John Radcliffe Hospital, Oxford, UK, with the
permission of Dr. Fiona Powrie. All mice maintained according
to EU regulations and experiments were performed under licence
from the Department of Health and with approval of the NU1
Maynooth Biology Department ethics committee. Mice were 6–8
wk old at the initiation of experiments.
 
Bacteria and Reagents. B. pertussis
 
 parental strain BP338 (Nal
 
r
 
derivative of Tohama 1) and FHA-depleted mutant BPM409
(24) were grown at 36
 
 
 
C in Stainer-Scholte medium. Heat-
killed 
 
B. pertussis
 
 for use in T cell assays were prepared by incu-
bation of cells at 90
 
 
 
C for 20 min and 
 
B. pertussis
 
 sonic extract
was prepared as described previously (14). Purified FHA and
PRN were prepared from 
 
B. pertussis
 
 Tohama 1 strain (14), and
were free of other 
 
B. pertussis
 
 proteins by analysis on SDS-
PAGE and free of LPS by analysis with an E-toxate kit (Sigma-
Aldrich). 
 
E. coli
 
 LPS (serotype 127:B8), Phosphorothioate-sta-
bilized oligodeoxynucleotide-containing CpG motifs (CpG-ODN)
(5
 
 
 
GCTAGACGTTAGCGT) were synthesized by Sigma-
Aldrich. OVA peptide 323–339 was synthesized by MWG-Bio-
tech AG.
 
B. pertussis Respiratory Challenge.
 
Bacteria from a 48 h culture
were concentrated to 2 
 
 
 
 10
 
10
 
/ml in PBS with 1% casein. Aero-
sol challenge was administered over 15 min using a nebulizer (0.5
ml/min). The course of 
 
B. pertussis
 
 infection was followed by
performing CFU counts on lungs from groups of four mice at
various times after aerosol challenge. Lungs were aseptically re-
moved and homogenized in 1 ml of sterile physiological saline
with 1% casein on ice. 100 
 
 
 
l of undiluted homogenate or of se-
rially diluted homogenate from individual lungs was spotted in
triplicate onto Bordet-Gengou agar plates, and the number of
CFU was estimated after 4 d of incubation at 37
 
 
 
C. Results are
reported as the mean number of 
 
B. pertussis
 
 CFU for individual
lungs from four mice per experimental group per time point.
 
Effect of FHA on DC Cytokine Production and Maturation.
 
Bone marrow–derived immature DCs were prepared by cultur-
ing bone marrow cells obtained from the femur and tibia of
BALB/c mice in RPMI-1640 and 10% FCS supplemented with
5–10% of a supernatant from a GM-CSF expressing cell line
(provided by Nathalie Winter, Institute Pasteur, Paris, France,
with permission of David Gray, University of Edinburgh, Edin-
burgh, UK). Cells were washed and recultured with fresh
RPMI/10% FCS containing 10% GM-CSF cell supernatant ev-
ery 3 d for a period of 8 d. Bone marrow–derived DCs (10
 
6
 
/ml)
were cultured at 37
 
 
 
C for 2 h in the presence or absence of FHA
(0.01–5 
 
 
 
g/ml) before stimulation with LPS from 
 
Escherichia coli
 
(1 
 
 
 
g/ml) and murine IFN-
 
 
 
 (20 ng/ml) or CpG-ODN (1 
 
 
 
g/
ml). In certain experiments anti–IL-10 mAb (10 
 
 
 
g/ml) was
added with the FHA. Alternatively, bone marrow–derived DCs
were incubated with sonic extracts of 
 
B. pertussis
 
 BP338 or
FHA
 
 
 
 mutant BPM409. Supernatants were removed after 24 h
for analysis of cytokine and chemokine concentrations or cells
were recovered, washed, and used for Immunofluorescence
analysis. IL-12p40, IL-12p70, IL-10, TGF-
 
 
 
, TNF-
 
 
 
, CCL3
(MIP-1
 
 
 
), CCL4 (MIP-1
 
 
 
), and MIP-2 concentrations were
measured by immunoassay using pairs of antibodies, purchased
from BD PharMingen or R&D Systems (IL-12p40 and p70), as
described (20).
 
Generation of T Cell Clones from B. pertussis–infected Mice.
 
T cells
were isolated from lung parenchyma and alveolar spaces from
mice 3 wk after aerosol challenge with 
 
B. pertussis
 
 as described
previously (18). Lung T cells (10
 
5
 
/ml) were cultured with splenic
APCs (irradiated spleen cells, 2 
 
 
 
 10
 
6
 
/ml) and FHA (5 
 
 
 
g/ml) or
PRN (5 
 
 
 
g/ml). IL-10 (200 pg/ml) was added with PRN but
not with FHA for the first two rounds of antigen stimulation. Af-
ter two rounds of antigen stimulation T cell lines were cloned by
limiting dilution. T cell clones were generated and maintained by
culture with FHA or PRN (1 
 
 
 
g/ml) and splenic APC for 4–5 d,
followed by 5–7 d culture with feeder cells and IL-2. Th1 and
Th2 clones specific for 
 
B. pertussis
 
 or influenza virus antigens 
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were generated as described previously (25, 26) from spleens of
mice that had recovered from respiratory infection with the re-
spective pathogen.
 
T Cell Cytokine Production.
 
T cell clones (10
 
5
 
/ml) and APCs
(irradiated spleen cells 2 
 
 
 
 10
 
6
 
/ml) or ex vivo spleen cells were
cultured with medium only or 
 
B. pertussis
 
 antigen (10
 
6
 
 killed bac-
teria/ml). Supernatants were removed after 1 d to test for IL-2
production or after 3 d to test for IL-4, IL-5, IL-10, IFN-
 
 
 
, and
TGF-
 
 
 
. IL-2 concentrations were determined using the CTLL
bioassay and other cytokines by specific immunoassays as de-
scribed (18). T cell proliferation was determined by [
 
3
 
H]thymi-
dine incorporation as described (14). The effect of Tr1 cells on
cytokine production by Th1 or Th2 cells was assessed in cocul-
ture experiments where the cells were cultured in the same wells
or in a Transwell system. Tr1 clones (10
 
5
 
/ml or 3 
 
 
 
 10
 
5
 
/ml)
were cultured alone or in the presence of Th1 or Th2 clones
(10
 
5
 
/ml) and APCs with the relevant antigen(s), either in the
same wells or separated by a semi-permeable membrane. In cer-
tain experiments a neutralizing anti–IL-10 mAb (10 
 
 
 
g/ml) was
added to the cultures. Supernatants were removed after 3 d and
tested for cytokine production and cells were pulsed with
[
 
3
 
H]thymidine after 4 d to test for proliferation.
 
Effect of Tr1 Clones on Th1 Responses and B. pertussis Infection In
Vivo.
 
Spleen cells were prepared from naive BALB/c mice or
mice that had recovered from infection with 
 
B. pertussis
 
 6 wk af-
ter challenge (immune spleen cells). Adoptive cell transfers was
performed into recipient mice that had been sublethally irradiated
to ablate their immune system (14). Groups of 12 recipient mice,
irradiated with 6 Gy total body irradiation 24 h earlier, were in-
jected intravenously with either naive spleen cells (2 
 
 
 
 10
 
7
 
), im-
mune spleen cells (2 
 
 
 
 10
 
7
 
) alone, or with Tr1 clones (2 
 
 
 
 10
 
5
 
).
Mice were challenge by aerosol inoculation with 
 
B. pertussis
 
 4 h
later (14). Four mice from each experimental group mice were
killed 7, 14, and 21 d after challenge. Lungs were removed to de-
termine 
 
B. pertussis
 
 CFU counts and spleen to determine T cell
responses. A proportion of the naive and immune spleen cells,
alone or with Tr1 clones, were also cultured with 
 
B. pertussis
 
 an-
tigen before in vivo transfer to determine the effect of Tr1 on
polyclonal T cell responses in vitro.
 
Bronchoalveolar Lavage.
 
Bronchoalveolar lavage (BAL) fluids
were obtained by injecting and aspirating in 0.5 ml volumes (total
4–5 ml) of warm RPMI-1640 via cannulation of the trachea. Cells
from the lavage fluids were recovered by centrifugation at 300 
 
g
 
for 5 min, and resuspended in RPMI-1640 with 8% FCS. For de-
tection of cytokine concentrations, BAL fluids were concentrated
fivefold using Centiprep-10 concentrators (Amicon Ltd.).
 
Generation of Tr1 Lines In Vitro from DO11.10 TCR Tg Mice.
 
GM-CSF amplified immature bone marrow–derived DCs were
cultured for 24 h with OVA peptide (0, 0.5, 5, 50 
 
 
 
g/ml) and
FHA (5 
 
 
 
g/ml), CpG-ODN (1 
 
 
 
g/ml), FHA, and anti–IL-10
(10 
 
 
 
g/ml) or medium only. Cells were washed and cultured at
10
 
5
 
/ml with naive T cells purified from DO11.10 TCR Tg mice
(10
 
6
 
/ml). After 4 d, fresh medium and IL-2 was added to the
cultures and fresh DCs, preincubated for 24 h with OVA peptide
and modulators as for the primary stimulation, were added after a
further 8 d. In the third and subsequent rounds of stimulation,
surviving T cells were cultured at 10
 
5
 
/ml with OVA peptide
(0.5, 5, 50 
 
 
 
g/ml) and splenic APCs (2 
 
 
 
 10
 
6
 
/ml). Supernatants
were removed after the second round of antigen stimulation and
concentrations of IL-4, IL-5, IL-10, and IFN-
 
 
 
 determined by
immunoassay.
 
Immunofluorescence Analysis.
 
Phenotypic analysis of T cell
clones was performed using PerCP-conjugated anti-CD3 (clone
 
145–2C11), PE-conjugated anti-CD28 (clone 37.51), anti-
CCR5 (clone C34–3448), anti–CTLA-4 (clone UC10–4F10–
11), PE/FITC-conjugated anti-CD4 (clone GK1.5), FITC-con-
jugated anti-CD25 (clone 7D4), and biotinylated rat anti–mouse
T1/ST2 (clone 3E10 (27), provided by Millennium Pharmaceu-
ticals Inc., Cambridge, MA) plus Extravidin-PE (Sigma-Aldrich).
Expression of DC surface markers was assessed using biotinylated
anti-CD11c (clone HL3) with Streptavidin-PerCP, PE-conju-
gated anti-CD80 (16–10A1), anti-CCR5 (clone C34–3448),
FITC-conjugated anti-CD86 (clone GL1), and FITC-conjugated
anti I-A
 
d
 
/I-E
 
d
 
 (clone 2G9). All antibodies, except anti-T1/ST2,
were purchased from BD PharMingen. Cells incubated with an
isotype matched directly conjugated antibody with irrelevant
specificity acted as a control. After incubation for 30 min at 4
 
 
 
C,
cells were washed and Immunofluorescence analysis was per-
formed on a FACScan™ (Becton Dickinson) and analyzed using
CELLQuest™ software. 10,000 cells were analyzed per sample.
 
Statistical Analysis.
 
Results, expressed as mean 
 
 
 
 SE, were
compared using the Student’s 
 
t
 
 test. 
 
P
 
 values 
 
 
 
0.05 were consid-
ered statistically significant.
 
Results
 
FHA Stimulates IL-10 Production by DCs and Inhibits LPS-
induced IL-12 and CCL3 Production.
 
We have demonstrated
previously that FHA inhibits macrophage IL-12 produc-
tion in vitro and IL-12 and IFN-
 
 
 
 production in vivo
in response to LPS (20). In this study we examined its ef-
fect on cytokine production and maturation of DCs. In-
cubation of immature bone marrow–derived DCs with
FHA stimulated significant levels of IL-10 (Fig. 1 A). Prein-
cubation of DCs with FHA suppressed LPS and IFN-
 
 
 
–
induced production of IL-12 p40 and IL-12p70 (Fig. 1 A)
and the 
 
 
 
-chemokine CCL3 (Fig. 1 B), but did not affect
the production of TNF-
 
 
 
 or MIP-2 or the viability of the
DCs (data not shown). The suppression of IL-12 and CCL3
was reversed in the presence of a neutralizing anti–IL-10
antibody (Fig. 1 B). Incubation of immature bone marrow–
derived DCs with LPS and IFN-
 
 
 
 (Fig. 2) or CpG-ODN
(data not shown) for 24 h resulted in enhanced expression
of MHC class II, B7–1, B7–2, CD40, and decreased ex-
pression of CCR5. Stimulation of DCs with FHA signifi-
cantly enhanced CD86, moderately enhanced CD40, but
did not affect expression of CD80 or CCR5 and compared
with LPS and IFN-
 
 
 
, FHA only had a marginal effect on
MHC class II expression (Fig. 2). Thus, FHA-stimulated
DCs have a distinct phenotype to the DC1 subtype and al-
though they have certain features of immature DCs they
may represent a distinct subtype of DCs.
 
B. pertussis-specific Tr1 Clones Generated from the Respira-
tory Tract in the Presence of Exogenous or Endogenous IL-10.
 
As FHA stimulated IL-10 production (Fig. 1), which ap-
pears to be required for Tr1 induction (1), and we had pre-
viously shown that local Th1 responses were suppressed in
vivo during acute infection with 
 
B. pertussis
 
 (18), we exam-
ined the hypothesis that the suppression was mediated by
the induction of pathogen-specific Tr1 cells. Tr1 cell lines
and clones specific for FHA and PRN were successfully
generated from lung T cells isolated from mice 21 d after 
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challenge with 
 
B. pertussis.
 
 Four PRN-specific Tr1-like T
cell lines were generated from lung tissue by culturing pu-
rified lung T cells with antigen in the presence of IL-10
and restimulation with antigen, splenic APCs, and IL-10.
Four FHA-specific Tr1-like T cell lines were generated
from lung T cells in the absence of exogenous IL-10. Here
the IL-10 was produced endogenously by FHA-stimulated
APCs in the culture. Using the same culture protocols Tr1-
type T cells could not be expanded from lungs of naive
mice or from spleen of 
 
B. petrussis
 
–infected or convalescent
mice. PRN and FHA-specific T cell clones were generated
from the established lung-derived T cell lines by cloning
at limiting dilution. The cloning efficiency was low, with
only two clones, from the four T cell lines at 10 cell/well
(96 wells per line), successfully maintained in culture and
expanded into 24-well plates and eventually into 25-ml
flasks. Clone FHA1.1 was specific for FHA and clone
TEK.1 was specific for PRN, neither clone responded to
other 
 
B. pertussis
 
 or unrelated antigens (influenza virus,
diphtheria toxoid, or ovalbumin). The Tr1 clones were
found to be slow cycling cells and proliferated 10–20-fold
less efficiently than Th1 clones. Nevertheless, they did se-
crete high levels of cytokines after stimulation with specific
antigen and APCs.
The Tr1 clones secreted high levels of IL-10 and IL-5,
but very low levels of IFN-
 
 
 
 and undetectable IL-2 or IL-4
(Fig. 3 A). One of the two Tr1 clones examined in detail
also secreted moderate levels of TGF-
 
 
 
. In contrast, Th1
clones generated from spleens of mice infected with 
 
B. per-
tussis
 
 or influenza virus antigens secreted IFN-
 
 
 
 and IL-2
but no IL-4, IL-5, IL-10, or TGF-
 
 
 
, whereas Th2 clones
generated from spleen of mice infected with 
 
B. pertussis
 
 se-
creted high levels of IL-4, IL-5, moderate IL-10, and no
IFN-
 
 
 
, IL-2, or TGF-
 
 
 
 (Fig. 3 A). A phenotypic analysis
of the Tr1 clones demonstrated that they shared certain
surface marker characteristics of both Th1 and Th2 cells
(CD4
 
 
 
, CD25
 
 
 
), but could be distinguished from Th1
cells on the basis of the expression of T1/ST2 and from
Th2 cells by the high expression of CCR5 (Fig. 3 B). Fur-
thermore expression of CD28 and CTLA-4 was weak on
Tr1 clones, significantly lower than that observed for Th1
or Th2 clones.
 
Tr1 Clones Suppress Protective Th1, but Not Th2, Responses
against B. pertussis.
 
Having demonstrated that 
 
B. pertussis
 
–
specific Tr1 cells isolated from the lung during this stage of
infection secreted IL-10 in response to specific antigen
stimulation, we examined the hypothesis that suppression
of local Th1 responses during 
 
B. pertussis
 
 infection (18) was
mediated in part by Tr1 cells. We first demonstrated that
the Tr1 clones were capable of inhibiting cytokine produc-
tion by a Th1 clone against an unrelated antigen, influenza
virus hemagglutinin (HA). IFN-
 
 
 
 production by the HA-
specific Th1 clone HDS2.6 was significantly suppressed af-
ter coincubation with the PRN-specific Tr1 clone TEK.1
Figure 1. FHA inhibits DC IL-12 and CCL3 pro-
duction by inducing IL-10. (A) Bone marrow–derived
DCs were stimulated with FHA alone or with FHA af-
ter 2 h with LPS (1  g/ml) and IFN-  (20 ng/ml). Af-
ter 24 h of culture, supernatants were removed and
IL-12p70 and IL-10 were determined by specific im-
munoassays. (B) DCs were preincubated with FHA (5
 g/ml) with or without anti–IL-10, followed 2 h later
with LPS (1  g/ml) and IFN-  (20 ng/ml). After 24 h
of culture, supernatants were removed and IL-12p70,
IL-12p40, CCL3, and IL-10 determined by specific im-
munoassays. Results are representative of six experiments. 
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(Fig. 4 A) or FHA-specific Tr1 clone FHA1.1 (Fig. 5 A).
Using Tr1 clone FHA1.1 we also observed significant inhi-
bition of proliferation (Fig. 5 B) and IL-2 production by
the Th1 clone (Th1 clone alone, 1,400 pg/ml IL-2; Th1
with Tr1, 150 pg/ml). The suppression was particularly
pronounced when the ratio of Tr1:Th1 cells was increased
from 1:1 to 3:1 (Fig. 5). Furthermore, the suppression was
still observed in a Transwell system where the Th1 and Tr1
clones were separated by a semi-permeable membrane
(Figs. 4 A and 5). Addition of a neutralizing anti–IL-10 an-
tibody to the cultures abrogated the suppressive effect of
the Tr1 clone (Fig. 5). Some reduction in IL-5 and IL-10
was observed across the membrane on the Th1, but not the
Tr1, side of the membrane (Fig. 4 A). This may reflect
incomplete equilibration of the cytokines across the
membrane; in later experiments twice daily mixing of the
cultures allowed more complete equilibration and less sig-
nificant differences between cytokine concentrations either
side of the membrane (Fig. 5, and data not shown). In con-
trast, the Tr1 clone had no effect on IL-4 production by
Th2 clones specific for the same or unrelated 
 
B. pertussis
 
antigens (Fig. 4 B).
We next examined the effect of the Tr1 clones on 
 
B.
pertussis
 
–specific Th1 responses in vitro and in vivo. Splenic
T cells from mice that had cleared an infection with 
 
B. per-
tussis
 
 secreted high levels of IFN-
 
 
 
 and low or undetectable
IL-4, IL-5, or IL-10, (Fig. 6 A), a classic Th1-type re-
sponse; we have previously demonstrated that CD4
 
 
 
 T
cells are the major source of this IFN-
 
 
 
 (14). In contrast,
spleen cells from naive mice did not secrete cytokines in re-
sponse to 
 
B. pertussis
 
 antigen. Coincubation of the 
 
B. per-
tussis
 
–specific Th1 cells with Tr1 clone TEK.1 completely
abrogated IFN-
 
 
 
 production. In contrast, significant levels
of IL-10 were observed in the supernatants of the cocul-
tured cells (Fig. 6 A). The effect of Tr1 cells on 
 
B. pertussis
 
–
specific Th1 cells and protection in vivo was determined
using adoptive transfer experiments with sublethally irradi-
ated mice. After transfer of T cells from naive mice, IFN-
 
 
 
could only be detected after 3 wk (data not shown) and the
course of infection was severe, with significant numbers of
bacteria still remaining in the respiratory tract at 3 wk (Fig.
6 C). Adoptive transfer of 
 
B. pertussis
 
–specific Th1 cells was
accompanied by significant 
 
B. pertussis
 
–specific IFN-
 
 
 
 pro-
duction by 7 d (Fig. 6 B) and complete bacterial clearance
by 3 wk (Fig. 6 C). After coadministration with Tr1 cells,
 
B. pertussis
 
–specific IFN-
 
 
 
 was significantly suppressed (Fig.
6 B) and the rate of bacterial clearance was delayed (Fig. 6
C). The poorer proliferative capacity of the Tr1, compared
with Th1, clone may have compromised their ability to ex-
ert more significant effect on the course of infection. Nev-
ertheless the numbers of bacteria in the lungs was 4–8-fold
greater after transfer of the Tr1 and Th1 cells than with the
 
B. pertussis
 
–specific Th1 cells alone (Fig. 6 C).
 
Enhanced Th1 Responses and Bacterial Clearance with B. per-
tussis FHA Mutant.
 
To provide further evidence that
FHA modulation of regulatory cytokine production, either
directly through binding to DCs, or indirectly through the
induction of Tr1 cells, may contribute to the immunosup-
pression observed we examined immune responses and the
course of infection with an FHA
 
 
 
 mutant of 
 
B. pertussis
 
,
BPM409
 
.
 
 The parent 
 
B. pertussis
 
 strain, BP338, caused a
protracted infection in naive mice, with bacteria still de-
tectable in the lungs for at least 5 wk after aerosol challenge
(Fig. 7 A). In contrast, the FHA
 
 
 
 mutant BPM409 was
completely cleared from the lungs within 3 wk of infection
(Fig. 7 A). The initial rise in bacterial counts after challenge
with the FHA
 
 
 
 mutant suggests that reduced adherence to
the cells of the respiratory tract does not account for all of
the loss of virulence observed.
An examination of local and systemic immune responses
in infected mice demonstrated that 
 
B. pertussis–
 
specific
IFN-
 
 
 
 production was significantly stronger in cells from
the lungs and local lymph node, but not significantly differ-
ent in spleens of FHA
 
 
 
 mutant compared with the parent
Figure 2. Influence of FHA on DC maturation. Bone marrow–derived
DCs were stimulated with LPS (1  g/ml) and IFN-  (20 ng/ml), FHA
(5  g/ml), or medium. After 24 h of culture, cells were washed and
immunofluorescence analysis performed for CD80, CD86, CD40,
MHC class II, and CCR5 (black histograms) or isotype-matched control
antibodies (gray histograms). Profiles are shown for a single experiment,
and are representative from four experiments.226 Bordetella pertussis-specific T Regulatory Cells in the Lung
Figure 3. Cytokine production
and phenotypic analysis of Tr1
clones generated from the respira-
tory tract of mice infected with B.
pertussis. (A) Tr1 clones were gener-
ated from lungs of mice 21 d after
aerosol challenge with B. pertussis.
TEK.1, specific for PRN was cloned
from a T cell line generated by stimu-
lation with antigen, APCs, and IL-10
(200 pg/ml). FHA1.1, specific for
FHA, was generated by stimulation
with antigen and APCs in the ab-
sence of exogenous IL-10. Th1
clones, HDS2.6 and 1A.12, specific
for influenza virus HA and B. pertus-
sis, respectively, and Th2 clones
PT1.1 and PRN2, specific for per-
tussis toxin and PRN, respectively,
were generated from spleens of in-
fluenza virus or B. pertussis–infected
mice. T cell clones were stimulated
with antigen and APCs. IL-2 con-
centrations were determined in 24 h
supernatants by CTLL bioassay and
IFN- , IL-4, IL-5, and IL-10 con-
centrations in 3-d supernatants were
determined by immunoassay. (B)
Th1 clone HDS2.6, Th2 clone
2PT2 (specific for pertussis toxin),
and Tr1 clone FHA1.1 were labeled
with antibodies specific for CD4,
CD25, CD28, CTLA4, CCR5, and
T1/ST2 and immunofluoresence
analysis performed on a FACScan™.
The dotted line indicated staining
with isotype matched control anti-
body. T cell clones were used at the end of the resting stage of the growth cycle, 7 d after addition of IL-2. Results are representative of three experi-
ments and results for B are shown for one Tr1 clone only, but were essentially identical to that found for the second Tr1 clone.
Figure 4. Tr1 clones inhibit cytokine production by Th1 but not Th2 clones.
(A) PRN-specific Tr1 clone TEK.1 (105/ml) and influenza virus HA-specific
Th1 clone HDS2.6 (105/ml) were cultured alone or together with PRN (5  g/
ml) and/or influenza virus (10 HAU/ml) and splenic APCs (2   106/ml). Super-
natants were removed after 2–3 d and concentrations of IL-4, IL-5, IL-10, and
IFN-  determined by immunoassays. In the cocultures, Tr1 and Th1 cells were
cultured in the same well, HDS2.6 plus TEK.1, or separated by a semi-perme-
able membrane, where supernatants were sampled from the Th1 side, HDS2.6
(TEK.1) or the Tr1 side, TEK.1 (HDS2.6). *P   0.05, **P   0.01, ***P   0.001
HDS2.6 alone versus cocultured with TEK.1. (B) PRN-specific Tr1 clone
TEK.1 was cultured with antigen alone or with PT-specific Th2 clone PT1.1 or
PRN-specificTh2 clone PRN2 and cytokine production assessed by immunoassay.
Results are representative of two experiments.227 McGuirk et al.
B. pertussis strain (Fig. 7 B). Furthermore, significant levels
of IL-10 were detected in BAL fluid during the acute phase
of infection with the parental BP338 strain, but not with
the FHA  mutant BPM409 (Fig. 7 C). A role for FHA in
suppression of protective Th1 responses during acute infec-
tion with B. pertussis in vivo was compatible with our ob-
servation that sonic extracts of FHA  mutant BPM409
stimulated higher IL-12 production by bone marrow–
derived DCs than the parent strain BP338 (BP338, 710  
80 pg/ml; BPM409, 2,100   120).
FHA-stimulated DCs Direct Naive T Cells Into a Regulatory
Phenotype In Vitro. Having already demonstrated that FHA
induced Tr1 cells in vivo and modifies cytokine produc-
tion and costimulatory molecule expression on DCs, we
sought to provide further evidence for the hypothesis that
FHA may drive DCs into a phenotype that selectively
enhances the induction of Tr1 cells. In these studies we
used the DO11.10 OVA TCR Tg mice as a source of na-
ive T cells. Immature bone marrow–derived DCs ex-
panded for 8 d in the presence of GM-CSF were cultured
for 24 h with OVA peptide (0, 0.5, 5, or 50  g/ml) alone
or with CpG ODN, FHA, or FHA and anti–IL-10 anti-
body and used as APCs for purified T cells from DO11.10
TCR Tg mice. DCs matured with CpG ODN selectively
enhanced the induction of Th1-type cells, with high IFN- 
Figure 5. Suppression of Th1 cell proliferation and IFN-  production
by Tr1 clone is mediated by IL-10. FHA-specific Tr1 clone FHA 1.1 and
influenza virus HA-specific Th1 clone HDS2.6 (105/ml) were cultured
alone (105/ml) or together at a ratio of 1:1 (105/ml) or 3:1 (3   105/ml:
105/ml) with FHA (5  g/ml) and/or influenza virus (10 HAU/ml) and
splenic APCs (2   106/ml). Cocultures were also performed in the pres-
ence a neutralizing anti-IL-10 antibody (10  g/ml). Supernatants were
removed after 3 d and concentrations of IFN-  determined by immu-
noassays. (A) Cells were harvested after 4 d and proliferation assessed by
[3H]thymidine incorporation (B). In the cocultures Tr1 and Th1 cells
were cultured in the same well, HDS.6 plus FHA1.1, or separated by a
semi-permeable membrane, where supernatants was sampled from the
Th1 side, HDS2.6 (FHA1.1) or the Tr1 side, FHA1.1 (HDS2.6). Prolif-
eration could only be assessed on the Th1 side of the membrane. *P  
0.05, **P   0.01, ***P   0.001 HDS2.6 alone versus cocultured with
FHA1.1. Results are representative of two experiments.
Figure 6. Tr1 clones suppress B. pertussis–specific IFN-  production in
vitro and in vivo. (A) Spleen cells from B. pertussis convalescent mice 6 wk
after challenge (designated Th1) were cultured at 2   106/ml with antigen
(B. pertussis sonic extract, 5  g/ml) alone or with Tr1 clone TEK.1 (105/
ml) and PRN (5  g/ml). Spleen cells from naive mice served as a control.
Supernatants were removed after 3 d and tested for IFN-  and IL-10 by
immunoassay. (B and C) Spleen cells from naive or convalescent mice
(designated Th1) were transferred into sublethally irradiated BALB/c
mice (2   107 per mouse) alone or with Tr1 clone TEK.1 (2   105 per
mouse). Mice were challenged with B. pertussis and killed 7, 14, and 21 d
later. (B) Spleen cells were isolated after 7 d and stimulated with B. pertus-
sis antigen and IFN-  concentrations determined in supernatants 3 d later.
(C) Lungs were removed and the number of viable B. pertussis deter-
mined by performing CFU counts. Results are mean (SD) for four mice
per group at each time point. *P   0.05, Th1 vs. Th1 plus Tr1. The re-
sults shown in A are representative of two experiments and due to the
large numbers of cells required the experiment shown in B and C were
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and low levels of IL-4, IL-5 and IL-10 (Fig. 8). In contrast,
T cells cultured with DCs that were stimulated with OVA
peptide and FHA directed the induction of Tr1-type T
cells, producing high IL-10, low IL-4, and moderate levels
of IL-5 and IFN- . Stable OVA-specific CD4  high IL-
10–secreting Tr1 cell lines were established from these cul-
tures by periodic restimulation with OVA peptide and
splenic APCs (data not shown). An examination of the sup-
pressive effect of an OVA-specific Tr1 line on the influenza
HA-specific Th1 clone revealed significant inhibition of
IFN-  production (Th1 alone, 140   16; Th1 plus Tr1, 95  
9: Th1 plus Tr1 plus anti–IL-10, 173   35 ng/ml). When
anti–IL-10 antibody was added to DCs during the 24 h in-
cubation with OVA and FHA, IL-10 and IL-5 production
by DO11.10 T cells was almost completely abrogated,
whereas IFN-  production was significantly elevated (Fig.
8). This suggests that IL-10 is an essential differentiation
factor for Tr1 cells. Taken together with our findings on B.
pertussis described above, our results demonstrate that the
induction of Tr1 cells is controlled by a subtype of DC that
secretes IL-10.
Discussion
Distinct subpopulations of CD4  T cells have been
shown to perform immunoregulatory functions in vitro
and in vivo, inhibiting Th1-mediated responses, either
through cell to cell contact or by releasing suppressive cy-
tokines (1–6, 28–31). It has been suggested that regulatory
T cells that secrete high levels of IL-10 or TGF- , termed
Tr1 and Th3 cells, respectively, may be prominent in the
gut and in other mucosal tissues, where they play key roles
in the maintenance of self-tolerance and the prevention of
autoimmune diseases (4). Although it has been speculated
that regulatory T cells may be directed against self-anti-
gens, bacteria, or parasites, little is know about their anti-
gen-specificity or induction in vivo (1, 28). The present
study describes for the first time the generation of Tr1
clones specific for a infectious pathogen and demonstrate
that the induction of Tr1 cells in the respiratory tract is di-
rected by a DC that secretes IL-10 in response to a patho-
gen-derived molecule.
As a result of their poor proliferative capacity and great
difficulty in expanding these cells in culture, only a small
Figure 7. Deletion of FHA attenuates local immunosuppression and enhances B. pertussis clearance form the lungs. Groups of 24 BALB/c mice were
challenged by exposure to an aerosol of B. pertussis BP338 or FHA  mutant BPM409. (A) The course of infection was followed by performing CFU
counts on the lungs of four mice per group at 3 h, 7, 14, 21, and 28 d after challenge. (B) Spleen, lymph nodes, and lung mononuclear cells were pre-
pared from mice 21 d after challenge and antigen-specific IFN-  production was tested by culturing with B. pertussis antigen and assessing cytokine levels
in supernatants 3 d later. (C) IL-10 concentrations in BAL fluid from mice 3–21 d after infection with B. pertussis BP338 or FHA  mutant BPM409. Re-
sults are representative of four experiments.
Figure 8. FHA stimulates DCs to direct naive T cells to
a Tr1 subtype. OVA-specific CD4  T cell lines were gen-
erated in vitro by stimulating purified naive T cells from
DO11.10 TCR Tg mice with DCs preincubated for 24 h
with OVA peptide (0, 0.5, 5, 50  g/ml) and FHA (5  g/
ml), CpG-ODN (1  g/ml), FHA, and anti–IL-10 (10  g/
ml) or medium only. After two rounds of antigen stimula-
tion supernatants were removed and concentrations of cy-
tokines determined by immunoassay. Results are represen-
tative of two experiments.229 McGuirk et al.
number of groups have successfully cultured antigen-spe-
cific Tr1 clones, mostly from naive T cells after repeated
stimulation in vitro in the presence of IL-10 (1, 3). A num-
ber of studies have also been performed with polyclonal
populations of T cells with regulatory activity, defined on
the basis of their specific surface marker expression.
CD4 CD25  regulatory T cells, which represent 5–10% of
CD4  T cells from spleen and lymph nodes of normal
mice, can suppress organ-specific autoimmune disease in
mice (29, 30). T cells with a CD4 CD38 CD45RBlow
phenotype have also been shown to function as regulatory
cells in vivo, preventing colitis induced by CD4 
CD45RBhi T cells (28, 30). The Tr1 clones generated in
the present study were CD4 , CD25 , CD28low, CTLAlow,
CCR5 , T1/ST2 . The expression of T1/ST2 and
CCR5 markers previously shown to be preferentially ex-
pressed on Th2 (32) and Th1 (33, 34) cells, respectively,
suggesting that they represent a phenotypically, as well as
functionally, distinct subtype of CD4  T cells. T1/ST2 is a
member of the IL-1 receptor family, but its ligand and pre-
cise function is still unknown. However, it has been shown
to play a critical role in Th2 responses, especially in the
lung, and is expressed on in vitro expanded Th2, but not
Th1, cells (27, 35). As IL-10 and IL-5 production is com-
mon to both populations, and T1/ST2 is expressed on Tr1
as well as Th2 cells, it is tempting to suggest that T1/ST2
may be involved in signaling for these cytokines. The low
expression of CTLA4 and CD28 is compatible with a phe-
notype of T cell found in the lungs during B. pertussis in-
fection (18); expression of other costimulatory molecules is
under investigation. The Tr1 clones described in this report
secreted high levels of IL-10 and lower levels of TGF- 
and IL-5 and suppressed proliferation, IFN-  and IL-2 pro-
duction by Th1 cells. Our results demonstrate for the first
time that pathogen-specific Tr1 cells suppress Th1 re-
sponses against distinct antigens on the same or unrelated
pathogens. Unlike the OVA-specific Tr1 clones generated
in vitro (3), our Tr1 clones did not suppress cytokine pro-
duction by Th2 cells and unlike the CD4 CD38 
CD45RBlow regulatory cells (28, 30) cell-to-cell contact
was not the predominant mechanism. Suppression was ob-
served across a semipermeable membrane and was com-
pletely reversed across the membrane and substantially
reversed in cocultures by anti–IL-10, suggesting that by-
stander suppression was largely mediated by IL-10.
Little is known about APCs and cytokines that promote
the induction of regulatory T cells in vivo. The produc-
tion of IL-12 and IL-4 by DCs or other innate cells and
activation of DC maturation into DC1 and DC2 by bind-
ing of pathogen-derived molecules appears to be a key
process in directing naive T cells to differentiate into Th1
and Th2 cells. LPS, dsRNA, and CpG ODN promote
maturation of DC1, which direct naive T cells to Th1 sub-
type (7, 9, 10). In contrast, phosphorylcholine-containing
glycoproteins derived from nematode parasites, cholera
toxin or yeast hyphae promote DC2, which selectively ac-
tivate Th2 cells (7, 11, 36). The results of the present study
demonstrate that activation of DCs that secrete IL-10, but
not IL-12, can direct naive T cells to a Tr1 subtype and
that the pathogen-derived molecule FHA from B. pertussis
can provide the stimulus. FHA binds to leukocyte response
integrin ( V 3, CD61) and integrin-associated protein
(CD47) complex and stimulates bacterial adherence to the
 2-integrin CR3 (CD11b/CD18,  M 2) (22). Engage-
ment of CR3 or CD47 on macrophages or DCs with spe-
cific antibodies or natural ligands has been shown to sup-
press IL-12 production (37–39), and this may represent a
physiological phenomenon for normal control of immune
responses in vivo. Our study demonstrates that B. pertussis
FHA can exploit this function by binding to these inte-
grins on DCs, inducing the production of IL-10, and in-
hibiting inflammatory chemokine and IL-12 production
and other aspects of DC1 maturation. It has been sug-
gested that immature DCs may promote the expansion of
IL-10–secreting or regulatory T cells (12, 40). While
FHA-activated DCs may have features of immature DCs,
they appear to represent a distinct subtype of DCs, with
enhanced expression of CD86 and CD40 over that seen
on immature DCs and in addition secrete high levels of
IL-10 after appropriate stimulation.
Analagous to the role of IL-12 in driving Th1 responses,
IL-10 appears to be the critical cytokine for the induction
of Tr1 cells. Interestingly most Tr1 clones generated to
date have employed IL-10 as a stimulating cytokine in the
culture medium (1, 3). The PRN-specific Tr1 clones gen-
erated in this study also required IL-10, but significantly,
the FHA-specific Tr1 clones were generated in the absence
of exogenous IL-10; here the IL-10 was produced endoge-
nously by FHA-stimulated APCs. Addition of an anti–IL-
10 antibody during culture of DCs with FHA and OVA
peptide abrogated the ability of the DCs to activate OVA-
specific Tr1 cells from the DO11.10 TCR Tg mice. How-
ever, IL-10 was not required for continuous culture of
PRN- or FHA-specific Tr1 clones. This suggests that IL-
10 is a critical differentiation but not growth factor for Tr1
cells. Recently it has been demonstrated that human CD4 
T cells primed in the presence of IL-10 and IFN-  differ-
entiate into Tr1 cells (41). Immature DCs from the respira-
tory tract express high levels of IL-10 mRNA (42). Like-
wise, immature DCs from liver (43) or Peyer’s patch (44)
secrete high levels of IL-10 and selectively induce IL-10 se-
creting alloreactive T cells or Th2 cells, respectively. This
may represent the default position at a mucosal surface, re-
sulting in a natural propensity to stimulate regulatory T
cells after stimulation with an appropriate self or foreign
antigen, a strategy for the maintenance of immunological
tolerance. We found that Tr1 clones could be generated at
low frequency from the lungs of B. pertussis–infected mice
and Th1 clones at higher frequency from spleen, but B. per-
tussis–specific T cells with Tr1-type cytokine profile could
not be generated from spleen of infected or convalesecent
mice or from the lungs of naive mice. These findings sug-
gests that in addition to the maintenance of tolerance, in-
duction of regulatory T cells at mucosal surfaces may be a
strategy evolved by pathogens to suppress protective Th1
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Antigen-specific Th1 responses in the lungs and local
lymph nodes are suppressed during acute infection with B.
pertussis (18). We found that deletion of FHA from B. per-
tussis partially reversed the immunosuppression in vivo and
enhanced the clearance of B. pertussis from the lungs. Al-
though we do not rule out the role of FHA in mediating
adherence to cells in the respiratory tract (22) or the role of
other virulence factors (19), whose influence would be re-
moved as a result of earlier bacterial clearance, our data
suggests that FHA has a major influence on immune
responses to B. pertussis or other pathogens in the lung. In-
deed we have already demonstrated that intranasally ad-
ministered FHA with influenza virus can suppress virus-
specific IFN-  production in the local lymph nodes (21).
During active infection with B. pertussis, the bacteria se-
crete high levels of FHA, which bind to CD61–CD47
complex and CD11b/CD18 (22) expressed on DC (39).
Immature DCs are normally resident in the respiratory tract
of rats and mice (41, and unpublished data). We have ob-
served transient recruitment and maturation of DCs in the
lungs after infection with B. pertussis and maturation was
more pronounced in mice infected with the FHA  mutant
(unpublished data). Furthermore, IL-12 production by
DCs in vitro was stronger with the FHA  mutant than
with the parent B. pertussis strain. Taken together with our
demonstration of inhibition of IL-12 and inflammatory
chemokines and stimulation of IL-10–producing DCs that
directs the induction of Tr1 cells, the net effect of FHA is
to inhibit the induction, activation and recruitment of Th1
cells. This represents a novel immune subversion strategy
employed by a respiratory tract pathogen to prolong its sur-
vival in the host.
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